U.S. Personal Products Stock News

Wondering if Stifel Financial, at a recent US$69.37 share price, is offering value or just noise? This article breaks down what that price could mean for you. The stock is down 1.8% over the past week and 9.2% over the past month, even though the 1 year return sits at 13.4% and the 3 year and 5 year returns are 83.9% and 76.5% respectively. Recent headlines around capital markets activity and the broader financial sector have kept investor attention on firms such as Stifel Financial. This...

Veracyte has recently reported strong Phase III clinical data for its Prosigna Breast and Decipher Prostate genomic tests at ASCO 2026 and confirmed the upcoming U.S. commercial launch of Prosigna on June 8, 2026 for early-stage hormone-receptor positive breast cancer patients. The new evidence suggests these tests can help oncologists tailor chemotherapy use more precisely, potentially sparing many high-risk breast and prostate cancer patients from unnecessary treatment and its long-term...

If you are wondering whether RTX at around US$172.55 a share offers fair value or is starting to look stretched, the valuation picture is the key place to focus. RTX's share price has pulled back slightly in the short term, declining 2.3% over the last week and 0.2% over the last month, and is also down 7.9% year to date, even though it is still up 26.5% over 1 year, 86.5% over 3 years and 116.8% over 5 years. These mixed returns arrive as investors continue to weigh broader defense and...

Yum! Brands has announced that longtime Chief Operating Officer and Chief People & Culture Officer Tracy Skeans will retire, with her transitioning from her current roles on November 1, 2026, into a Senior Advisor position until March 1, 2028. Her planned retirement marks the departure of a key architect of Yum!’s franchising model and culture, prompting a multi‑year leadership transition as the company recruits a new Chief People & Culture Officer and a new Chief Scale Officer. With this...

Nuvation Bio (NUVB) is back in focus after reporting new patient-reported outcomes from its pivotal TRUST-II study of IBTROZI in advanced ROS1+ non small cell lung cancer, alongside fresh regulatory milestones. See our latest analysis for Nuvation Bio. The recent TRUST-II data and regulatory updates arrive after a mixed share price pattern, with a 30 day share price return of 7.03% and a year to date share price decline of 44.99%, while the 1 year total shareholder return is 92.65% and the 3...

Cognizant Technology Solutions (NasdaqGS:CTSH) expanded its AI collaboration with Snowflake to deploy AI-powered intelligent agents at scale across industries. The companies aim to help enterprises adopt AI more quickly, with a focus on AI-driven business workflows and measurable operational outcomes. Cognizant also broadened its alliance with CrowdStrike to address security and governance needs tied to large-scale AI deployments. Cognizant sits at the intersection of IT services, cloud...

LightPath Technologies (NasdaqCM:LPTH) has completed a follow-on equity offering via a registered direct deal. The company raised gross proceeds of US$50 million. Management plans to use the new capital for working capital, investments, acquisitions, and other corporate purposes. LightPath Technologies focuses on photonics solutions, supplying optical components and related products into areas where demand for high precision optics has been growing across multiple applications. This fresh...

If you are wondering whether XP at around US$15.60 is starting to look like a bargain or still carries too much risk, the recent share performance gives you some important clues. The stock has fallen about 9% over the past week, around 15.7% over the past month, and is down 19.5% over the past year. This may change how investors think about both its potential and its risks. Recent coverage of XP has focused on how the stock has pulled back over different timeframes and what that says about...

Some investors may be wondering whether Blue Bird's share price still offers value after a strong run, or if most of the opportunity has already been priced in. The stock last closed at US$72.43, with returns of 2.2% over 7 days, 15.2% over 30 days, 54.9% year to date and 85.6% over the past year. Recent coverage has focused on how this long term share price performance has sharpened the market's focus on what Blue Bird might be worth compared with its current price. Investors are watching...

Georgia Power, a subsidiary of Southern Company (NYSE:SO), appointed Anthony Oni as vice president of Corporate Affairs. The company also highlighted significant investments in grid upgrades as the Atlantic hurricane season begins. The announcement links a leadership change with operational preparations for severe weather events affecting Georgia Power's service territory. Southern, through Georgia Power, operates in a sector where reliability and storm readiness are core to the business...

In recent days, Concentrix has been recognized on the Fortune 500 list for the third consecutive year, advanced its AI-powered iX and agentic platforms, and reported revenue and profitability in line with guidance while continuing to manage debt and invest in growth. Together, these developments highlight how Concentrix is positioning itself as an AI-focused customer experience partner at a time when enterprises are rethinking how people, technology, and automation work together. Next, we’ll...

Why Global Net Lease is on investors’ radar today Global Net Lease (GNL) has been drawing fresh attention after recent trading left the stock at a last close of US$9.21, prompting investors to reassess its income focused real estate footprint. See our latest analysis for Global Net Lease. The share price has eased in recent sessions, with a 1-day share price return of a 1.50% decline and a 7-day share price return of a 2.85% decline. However, the 1-year total shareholder return of 33.29% and...

Blaize Holdings (BZAI) is in focus after its joint presence with Winmate at COMPUTEX 2026 in Taipei, where the companies are showing rugged edge AI systems built around Blaize’s GSP-based AI acceleration. See our latest analysis for Blaize Holdings. Despite the COMPUTEX spotlight and partnerships around edge AI, Blaize Holdings’ share price has been volatile, with a 90-day share price return of 52.99% but a 1-year total shareholder return that declined 27.82%. This indicates short term...

Wondering if Credo Technology Group Holding is priced for more upside or already reflects the buzz around it? This article focuses squarely on what the current share price might be implying. The stock last closed at US$214.60, after a 19.2% gain over the past 30 days and a 49.8% return year to date. Over the last 7 days it saw a 3.0% decline, and the 1 year return sits at 180.7% with a very large 3 year gain. These moves have put Credo on many investors' radars, especially given the strong 1...

TJX Companies (NYSE:TJX) served as headline sponsor of the 27th Annual Best Buddies Challenge. The event raised over US$4m to support people with intellectual and developmental disabilities. This philanthropic effort highlights TJX Companies' focus on community engagement and social responsibility. TJX Companies, the off price retailer behind brands like T.J. Maxx and Marshalls, is known primarily for its value focused apparel and home goods offering. This large scale support of the Best...

Boyd Gaming (NYSE:BYD) is moving ahead with several major property projects, including the new Cadence Crossing Casino in Las Vegas. The company is progressing a large resort development in Virginia that is planned as a key addition to its regional portfolio. Regulators have approved a significant expansion at Boyd’s Illinois property, clearing the way for further build out. For you as an investor, these projects matter because they show how Boyd Gaming is allocating capital across core...

Ziff Davis (ZD) just reported Q1 results with lower revenue and adjusted EBITDA, weighed down by Tech & Shopping, while management pushed ahead with asset sales, share repurchases, and greater use of AI across its portfolio. See our latest analysis for Ziff Davis. At a share price of US$44.54, Ziff Davis has given shareholders a 31.04% year to date share price return and a 36.25% total shareholder return over one year. However, the 3 year and 5 year total shareholder returns are down 33.70%...

BridgeBio Pharma announced that the FDA previously accepted and granted Priority Review to its New Drug Application for oral BBP-418 in LGMD2I/R9, setting a PDUFA target action date of November 27, 2026, without planning an advisory committee meeting. If approved, BBP-418 would be the first therapy for LGMD2I/R9 and any limb-girdle muscular dystrophy, potentially qualifying BridgeBio for a Priority Review Voucher and opening up further rare disease development paths. We’ll now examine how...

Ituran Location and Control (ITRN) is drawing attention after first quarter 2026 earnings, paired with a new dividend, updates on share repurchases, and a fresh shelf registration filing that expands future funding options. See our latest analysis for Ituran Location and Control. Those capital moves and the stronger first quarter backdrop come after a powerful run in the stock, with the share price up 52.99% year to date and an 83.48% total shareholder return over the past year, pointing to...

UGI Corporation recently released its 2025 ESG Report, confirming it met all of its stated 2025 ESG commitments and highlighting progress on emissions reductions, safety metrics, board independence and AI governance, while the Pennsylvania Public Utility Commission scheduled public hearings on UGI Utilities’ proposed US$17.3 million annual electric rate increase that could lift typical residential bills by 12.8%. Together, the rate case hearings and the company’s comprehensive ESG...

In the last week, the United States market has stayed flat, yet it is up 26% over the past year with earnings forecast to grow by 17% annually. In such a robust market environment, identifying stocks trading below their intrinsic value can present unique opportunities for investors seeking potential growth.

The market remained flat over the last week, but it is up 26% over the past year, with earnings forecast to grow by 17% annually. Investing in penny stocks—once a buzzword but now more of a niche—can still open doors to growth opportunities, typically in smaller or newer companies. We've identified three penny stocks that combine balance sheet strength with potential for outsized gains, giving investors the chance to discover hidden value in quality companies.

Over the last 7 days, the United States market has remained flat, though it has seen a significant rise of 26% over the past year, with earnings forecasted to grow by 17% annually. In this environment, growth companies with high insider ownership can be particularly appealing as they often indicate strong confidence from those who know the business best.

Over the last 7 days, the United States market has remained flat, yet it has seen a significant rise of 26% over the past year with earnings forecasted to grow by 17% annually. In such a dynamic environment, dividend stocks yielding up to 4.9% can offer investors an attractive combination of income and potential growth stability.